These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38534728)

  • 21. T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.
    Vlachonikola E; Stamatopoulos K; Chatzidimitriou A
    Front Immunol; 2020; 11():612244. PubMed ID: 33552073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.
    Blanco G; Puiggros A; Sherry B; Nonell L; Calvo X; Puigdecanet E; Chiu PY; Kieso Y; Ferrer G; Palacios F; Arnal M; Rodríguez-Rivera M; Gimeno E; Abella E; Rai KR; Abrisqueta P; Bosch F; Calon A; Ferrer A; Chiorazzi N; Espinet B
    Exp Hematol; 2021 Mar; 95():68-80. PubMed ID: 33421548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia.
    Sordo-Bahamonde C; Lorenzo-Herrero S; González-Rodríguez AP; Payer ÁR; González-García E; López-Soto A; Gonzalez S
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia.
    Lewinsky H; Barak AF; Huber V; Kramer MP; Radomir L; Sever L; Orr I; Mirkin V; Dezorella N; Shapiro M; Cohen Y; Shvidel L; Seiffert M; Herishanu Y; Becker-Herman S; Shachar I
    J Clin Invest; 2018 Dec; 128(12):5465-5478. PubMed ID: 30277471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tim-3 and PD-1 blocking cannot restore the functional properties of natural killer cells in early clinical stages of chronic lymphocytic leukemia: An
    Astaneh M; Rezazadeh H; Hossein-Nataj H; Shekarriz R; Zaboli E; Shabani M; Asgarian-Omran H
    J Cancer Res Ther; 2022; 18(3):704-711. PubMed ID: 35900543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Checkpoint Molecules Expressed on CD4
    Cui D; Jiang D; Yan C; Liu X; Lv Y; Xie J; Chen Y
    Front Microbiol; 2022; 13():887408. PubMed ID: 35572697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ibrutinib treatment improves T cell number and function in CLL patients.
    Long M; Beckwith K; Do P; Mundy BL; Gordon A; Lehman AM; Maddocks KJ; Cheney C; Jones JA; Flynn JM; Andritsos LA; Awan F; Fraietta JA; June CH; Maus MV; Woyach JA; Caligiuri MA; Johnson AJ; Muthusamy N; Byrd JC
    J Clin Invest; 2017 Aug; 127(8):3052-3064. PubMed ID: 28714866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients.
    Monserrat J; Sánchez MÁ; de Paz R; Díaz D; Mur S; Reyes E; Prieto A; de la Hera A; Martínez-A C; Alvarez-Mon M
    Cytometry B Clin Cytom; 2014 Jan; 86(1):32-43. PubMed ID: 24166938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated levels of circulatory follicular T helper cells in chronic lymphocytic leukemia contribute to B cell expansion.
    Le Saos-Patrinos C; Loizon S; Zouine A; Turpin D; Dilhuydy MS; Blanco P; Sisirak V; Forcade E; Duluc D
    J Leukoc Biol; 2023 Mar; 113(3):305-314. PubMed ID: 36807447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological Study of PD-1/PD-L1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with Emphasis on Large B-Cell Richter Transformation.
    Masoud R; Eladl AE; El-Ashwah S; Abbas A; Kandil W
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4243-4252. PubMed ID: 38156860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.
    Pal Singh S; de Bruijn MJW; de Almeida MP; Meijers RWJ; Nitschke L; Langerak AW; Pillai SY; Stadhouders R; Hendriks RW
    Front Immunol; 2018; 9():1996. PubMed ID: 30271400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-G expression as a prognostic indicator in B-cell chronic lymphocytic leukemia.
    Attia MA; Nosair NA; Gawally A; Elnagar G; Elshafey EM
    Acta Haematol; 2014; 132(1):53-8. PubMed ID: 24557341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease.
    Tötterman TH; Carlsson M; Simonsson B; Bengtsson M; Nilsson K
    Blood; 1989 Aug; 74(2):786-92. PubMed ID: 2787679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered T Follicular Helper Cell Subsets and Function in Chronic Lymphocytic Leukemia.
    Wu X; Fajardo-Despaigne JE; Zhang C; Neppalli V; Banerji V; Johnston JB; Gibson SB; Marshall AJ
    Front Oncol; 2021; 11():674492. PubMed ID: 33996605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming.
    Martinez Marignac VL; Smith S; Toban N; Bazile M; Aloyz R
    Oncotarget; 2013 Dec; 4(12):2550-66. PubMed ID: 24334291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.
    Pulte D; Furman RR; Broekman MJ; Drosopoulos JH; Ballard HS; Olson KE; Kizer JR; Marcus AJ
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):367-72. PubMed ID: 21816376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group.
    Shvidel L; Tadmor T; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Klepfish A; Ruchlemer R; Berrebi A; Polliack A;
    Eur J Haematol; 2014 Jul; 93(1):29-33. PubMed ID: 24547751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T-cells in chronic lymphocytic leukemia.
    Rissiek A; Schulze C; Bacher U; Schieferdecker A; Thiele B; Jacholkowski A; Flammiger A; Horn C; Haag F; Tiegs G; Zirlik K; Trepel M; Tolosa E; Binder M
    Int J Cancer; 2014 Nov; 135(10):2370-9. PubMed ID: 24723150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.